- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT07588035
Artificial Intelligence (AI)-Assisted Sleep Intervention for Insomnia in Older Adults With Subjective Cognitive Decline
8 maj 2026 uppdaterad av: The Hong Kong Polytechnic University
Artificial Intelligence (AI)-Assist Sleep Intervention for Insomnia Among Older Adults With Subjective Cognitive Decline: A Pilot Randomized Controlled Trial
To assess the feasibility and acceptability of Artificial Intelligence (AI)-assisted sleep intervention on improving the insomnia of older adults with subjective cognitive decline.
Studieöversikt
Status
Har inte rekryterat ännu
Betingelser
Intervention / Behandling
Detaljerad beskrivning
This is a two-arm pilot randomized controlled trial evaluating the feasibility and acceptability of Artificial Intelligence (AI)-assisted sleep intervention on improving the insomnia of older adults with subjective cognitive decline.
Sixty participants will be rectuited.
Participants in the intervention group will receive a 6-week AI-assisted sleep intervention, while those in the control group will receive usual care.
Outcomes including feasibility and acceptability of the AI-assisted sleep intervention, insomnia, beliefs and attitudes of sleep, depression, and anxiety will be measured at baseline and immediately post intervention.
Studietyp
Interventionell
Inskrivning (Beräknad)
60
Fas
- Inte tillämpbar
Kontakter och platser
Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.
Studiekontakt
- Namn: Shanshan Prof. Wang, PhD
- Telefonnummer: +85227664696
- E-post: shan-shan.wang@polyu.edu.hk
Studieorter
-
-
Guangdong
-
Qingyuan, Guangdong, Kina, 511800
- Qingyuan Second People's Hospital
-
Kontakt:
- Yuting Xia
- Telefonnummer: +8613940095971
- E-post: yuting.xia@connect.polyu.hk
-
-
Deltagandekriterier
Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.
Urvalskriterier
Åldrar som är berättigade till studier
- Vuxen
- Äldre vuxen
Tar emot friska volontärer
Nej
Beskrivning
Inclusion Criteria:
- older adults aged ≥ 60 years
- Subjective cognitive decline questionnaire 9 (SCD-Q9) ≥ 5
- Montreal Cognitive Assessment (MoCA) ≥ 26. If the number of years of education is less than 12, one point will be added to the total score;
- with insomnia according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) and Insomnia Severity Index (ISI) ≥ 8
- reachable by phone
Exclusion Criteria:
- having a previously diagnosed primary sleep disorder, such as sleep apnoea
- suffering from a severe chronic illness that could contribute to sleep problems (e.g., emphysema)
- currently undergoing medical, psychological, or psychiatric treatment for sleep disturbances or depression
- having significant visual or hearing impairments.
Studieplan
Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Stödjande vård
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Enda
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Aktiv komparator: Vanlig skötsel
|
The standard care participants receive from the healthcare system and/or their daily routines to address insomnia symptoms
|
|
Experimentell: Artificial Intelligence (AI)-assisted sleep intervention
|
Six weeks of AI-assisted sleep intervention
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Eligibility rate
Tidsram: Pre-intervention
|
The number of screened participants who will be eligible.
|
Pre-intervention
|
|
Recruitment rate
Tidsram: Pre-intervention
|
The number of participants enrolled in the study
|
Pre-intervention
|
|
Adherence rate
Tidsram: Immediately post-intervention
|
The number of participants in the intervention and control groups who complete the intervention
|
Immediately post-intervention
|
|
Attrition rate
Tidsram: Immediately post-intervention
|
The percentage of enrolled participants who discontinue participation at any point during the study.
|
Immediately post-intervention
|
|
Engagement rate
Tidsram: Immediately post-intervention
|
The degree of mastery and use of the intervention content, measured by sleep diary data.
|
Immediately post-intervention
|
|
Retention rate
Tidsram: Immediately post-intervention
|
The number of participants who remain in the study
|
Immediately post-intervention
|
|
Acceptability
Tidsram: Immediately post-intervention
|
Participants' perceptions of and satisfaction with the intervention will be assessed through individual interviews.
|
Immediately post-intervention
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Insomnia
Tidsram: Pre-intervention and immediately post-intervention
|
Insomnia will be measured by Insomnia Severity Index (ISI) and actigraphy.
The total score on ISI ranges from zero to 28 points, with a higher score indicating more severe insomnia.
A total score between 0 and 7 indicates no clinical insomnia; a score of 8 to 14 suggests subthreshold insomnia; 15 to 21 indicates moderate insomnia; and 22 to 28 indicates severe insomnia.
The actigraphy will be used in this study is Xiaomi Mi Band 10.
|
Pre-intervention and immediately post-intervention
|
|
Beliefs and attitudes of sleep
Tidsram: Pre-intervention and immediately post-intervention
|
Beliefs and attitudes of sleep will be measured by the Dysfunctional Beliefs and Attitudes about Sleep Scale-16 (DBAS-16).
The total score of the scale is 16-80 points.
The higher the total score, the more correct the belief and attitude towards sleep.
|
Pre-intervention and immediately post-intervention
|
|
Depression
Tidsram: Pre-intervention and immediately post-intervention
|
Depression will be measured by 15-item Geriatric Depression Scale (GDS-15).
The total score on the scale ranges from zero to 15 points, with the total score above eight points indicating the presence of depression.
Higher scores indicate more severe depression.
|
Pre-intervention and immediately post-intervention
|
|
Anxiety
Tidsram: Pre-intervention and immediately post-intervention
|
Anxiety will be measured by Generalized Anxiety Disorder Scale.
The total score of the scale is 0-21 points, with no anxiety below 5 points, mild anxiety of 5-9 points, moderate anxiety of 10-14 points, and severe anxiety above 14 points.Higher scores indicate more severe anxiety.
|
Pre-intervention and immediately post-intervention
|
Samarbetspartners och utredare
Det är här du hittar personer och organisationer som är involverade i denna studie.
Studieavstämningsdatum
Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.
Studera stora datum
Studiestart (Beräknad)
20 april 2026
Primärt slutförande (Beräknad)
1 september 2027
Avslutad studie (Beräknad)
1 september 2027
Studieregistreringsdatum
Först inskickad
17 april 2026
Först inskickad som uppfyllde QC-kriterierna
8 maj 2026
Första postat (Faktisk)
14 maj 2026
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
14 maj 2026
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
8 maj 2026
Senast verifierad
1 april 2026
Mer information
Termer relaterade till denna studie
Nyckelord
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- HSEARS20251101004
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
NEJ
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Nej
Studerar en amerikansk FDA-reglerad produktprodukt
Nej
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .